ArticleFrontiers in oncology2025

Pan-cancer analysis reveals ELFN1 as a novel prognostic biomarker and immunotherapeutic target associated with tumor microenvironment remodeling and promoting malignant phenotypes in colorectal cancer.

Sha-Sha Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.